BNP Paribas Financial Markets Sells 99,370 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

BNP Paribas Financial Markets reduced its position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 62.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 60,021 shares of the medical instruments supplier's stock after selling 99,370 shares during the quarter. BNP Paribas Financial Markets owned about 0.15% of AngioDynamics worth $550,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. SBI Securities Co. Ltd. purchased a new stake in shares of AngioDynamics in the fourth quarter worth $28,000. R Squared Ltd bought a new stake in shares of AngioDynamics during the 4th quarter valued at about $49,000. US Bancorp DE grew its holdings in shares of AngioDynamics by 1,938.0% during the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock worth $61,000 after purchasing an additional 6,376 shares in the last quarter. Quinn Opportunity Partners LLC purchased a new position in shares of AngioDynamics during the fourth quarter worth about $92,000. Finally, OneDigital Investment Advisors LLC raised its stake in AngioDynamics by 14.0% in the fourth quarter. OneDigital Investment Advisors LLC now owns 12,137 shares of the medical instruments supplier's stock valued at $111,000 after purchasing an additional 1,490 shares in the last quarter. Institutional investors own 89.43% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a "buy" rating and issued a $16.00 target price (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Price Performance

AngioDynamics stock traded down $0.26 during mid-day trading on Thursday, hitting $10.00. The company's stock had a trading volume of 812,037 shares, compared to its average volume of 558,107. The business has a 50 day moving average price of $9.47 and a 200-day moving average price of $9.55. AngioDynamics, Inc. has a 12 month low of $5.47 and a 12 month high of $13.50. The stock has a market cap of $406.07 million, a price-to-earnings ratio of -1.78 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last issued its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The company had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The firm's quarterly revenue was down 4.3% compared to the same quarter last year. On average, equities research analysts expect that AngioDynamics, Inc. will post -0.37 earnings per share for the current fiscal year.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.